Related references
Note: Only part of the references are listed.Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
A phase I/IIa study on antisense compound PRO051 in patients with Duchenne muscular dystrophy
N. M. Goemans et al.
NEUROMUSCULAR DISORDERS (2009)
Therapeutic Potential of Splice-Switching Oligonucleotides
John Bauman et al.
OLIGONUCLEOTIDES (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
Elizabeth R. Rayburn et al.
DRUG DISCOVERY TODAY (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of Exon 51 during dystrophin Pre-mRNA splicing in human muscle
V. Arechavala-Gomeza et al.
HUMAN GENE THERAPY (2007)
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Eric E. Swayze et al.
NUCLEIC ACIDS RESEARCH (2007)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Population doubling: A simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results
SK Greenwood et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2004)
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
A Aartsma-Rus et al.
HUMAN MOLECULAR GENETICS (2003)
Early prednisone treatment in Duchenne muscular dystrophy
L Merlini et al.
MUSCLE & NERVE (2003)
Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient
Y Takeshima et al.
BRAIN & DEVELOPMENT (2001)
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells
JCT van Deutekom et al.
HUMAN MOLECULAR GENETICS (2001)
Cross-talk between pro-inflammatory transcription factors and glucocorticoids
IM Adcock et al.
IMMUNOLOGY AND CELL BIOLOGY (2001)